These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 29123526)

  • 1. Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages.
    Müller E; Christopoulos PF; Halder S; Lunde A; Beraki K; Speth M; Øynebråten I; Corthay A
    Front Immunol; 2017; 8():1383. PubMed ID: 29123526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation.
    Müller E; Speth M; Christopoulos PF; Lunde A; Avdagic A; Øynebråten I; Corthay A
    Front Immunol; 2018; 9():2520. PubMed ID: 30450098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for dissociation of TLR mRNA expression and TLR agonist-mediated functions in bovine macrophages.
    Franchini M; Schweizer M; Mätzener P; Magkouras I; Sauter KS; Mirkovitch J; Peterhans E; Jungi TW
    Vet Immunol Immunopathol; 2006 Mar; 110(1-2):37-49. PubMed ID: 16216336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha.
    Ghosh TK; Mickelson DJ; Solberg JC; Lipson KE; Inglefield JR; Alkan SS
    Int Immunopharmacol; 2007 Aug; 7(8):1111-21. PubMed ID: 17570328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome.
    Manfrere KC; Torrealba MP; Miyashiro DR; Oliveira LM; de Carvalho GC; Lima JF; Branco AC; Pereira NZ; Pereira J; Sanches JA; Sato MN
    Oncotarget; 2016 Nov; 7(46):74592-74601. PubMed ID: 27780938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
    Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
    Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
    Howard AD; Erickson KL
    Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
    Hori K; Mihich E; Ehrke MJ
    Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.
    Pinhal-Enfield G; Ramanathan M; Hasko G; Vogel SN; Salzman AL; Boons GJ; Leibovich SJ
    Am J Pathol; 2003 Aug; 163(2):711-21. PubMed ID: 12875990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flagellin or lipopolysaccharide treatment modified macrophage populations after colorectal radiation of rats.
    Lacavé-Lapalun JV; Benderitter M; Linard C
    J Pharmacol Exp Ther; 2013 Jul; 346(1):75-85. PubMed ID: 23596059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity.
    Cox GW; Melillo G; Chattopadhyay U; Mullet D; Fertel RH; Varesio L
    J Immunol; 1992 Nov; 149(10):3290-6. PubMed ID: 1431106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR-4 Agonist Induces IFN-γ Production Selectively in Proinflammatory Human M1 Macrophages through the PI3K-mTOR- and JNK-MAPK-Activated p70S6K Pathway.
    Gajanayaka N; Dong SXM; Ali H; Iqbal S; Mookerjee A; Lawton DA; Caballero RE; Cassol E; Cameron DW; Angel JB; Crawley AM; Kumar A
    J Immunol; 2021 Nov; 207(9):2310-2324. PubMed ID: 34551966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
    Proost P; Verpoest S; Van de Borne K; Schutyser E; Struyf S; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J
    J Leukoc Biol; 2004 May; 75(5):777-84. PubMed ID: 14996826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-inflammatory response ensured by LPS and Pam3CSK4 in RAW 264.7 cells did not improve a fungistatic effect on
    de Campos GY; Oliveira RA; Oliveira-Brito PKM; Roque-Barreira MC; da Silva TA
    PeerJ; 2020; 8():e10295. PubMed ID: 33304649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll like receptor 2 agonists lipoteichoic acid and peptidoglycan are able to enhance antigen specific IFNγ release in whole blood during recall antigen responses.
    Dammermann W; Wollenberg L; Bentzien F; Lohse A; Lüth S
    J Immunol Methods; 2013 Oct; 396(1-2):107-15. PubMed ID: 23954282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyapatite nanoparticles promote TLR4 agonist-mediated anti-tumor immunity through synergically enhanced macrophage polarization.
    Wang R; Hua Y; Wu H; Wang J; Xiao YC; Chen X; Ao Q; Zeng Q; Zhu X; Zhang X
    Acta Biomater; 2023 Jul; 164():626-640. PubMed ID: 37086827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
    Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P
    J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of adenosine receptor agonists on cytokine release by human mononuclear cells depends on the specific Toll-like receptor subtype used for stimulation.
    Ramakers BP; Riksen NP; Rongen GA; van der Hoeven JG; Smits P; Pickkers P
    Cytokine; 2006 Jul; 35(1-2):95-9. PubMed ID: 16963274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.